# X4 Pharmaceuticals, Inc: Form 8-K, filed Sep 17, 2025

- Company: [X4 Pharmaceuticals, Inc](/companies/xfor.md) (CIK 1501697)
- Form: 8-K
- Filed: 2025-09-17
- Accepted by EDGAR: Sep 17, 2025, 07:03 ET
- Period: 2025-09-15
- Accession: 0001501697-25-000021
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1501697/000150169725000021/xfor-20250915.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1501697/000150169725000021/

## Items reported

- Item 2.05: Exit or disposal costs
- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1501697/000150169725000021/xfor-20250915.htm

Filed Sep 17, 2025.
Source: SEC EDGAR, the filing index for accession 0001501697-25-000021. Last ingested by Listed: Nov 15, 2026, 04:16 ET. No prices; not investment advice.
